Natera Inc (NAS:NTRA)
$ 162.39 0.4 (0.25%) Market Cap: 21.44 Bil Enterprise Value: 20.99 Bil PE Ratio: 0 PB Ratio: 22.95 GF Score: 70/100

Natera Inc at Goldman Sachs Healthcare Conference Transcript

Jun 13, 2023 / 09:40PM GMT
Release Date Price: $50.72 (+2.53%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

All right, everybody. Thank you very much for joining this afternoon. I'm Matt Sykes, the Life Science Tools and Diagnostics Analyst at Goldman Sachs. I have the pleasure welcoming the management team from Natera today, Steve Chapman, CEO; and Mike Brophy, CFO. Steve, Mike, thanks very much for joining us today.

Steven Leonard Chapman
Natera, Inc. - CEO, President & Director

Thanks, Matt.

Michael B. Brophy
Natera, Inc. - CFO

Thanks for having us.

Questions & Answers

Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Maybe -- if you could maybe help set the stage first, talk about the most recent results, kind of some of the trends you're seeing in the business, what to expect for '23? And maybe sort of -- for those who might be new to the story, just a brief summary of the business model and some of the main areas where you're

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot